Last update 21 Nov 2024

Bulumtatug fuvedotin

Overview

Basic Info

Drug Type
Antibody drug conjugate (ADC)
Synonyms
Anti-nectin-4 IgG1 monoclonal antibody conjugated to monomethyl auristatin E (Mabwell), 9MW 2821, 9MW-2821
+ [1]
Mechanism
Tubulin inhibitors, nectin-4 inhibitors(Nectin-4 inhibitors)
Inactive Indication-
Inactive Organization-
Drug Highest PhasePhase 3
First Approval Date-
RegulationFast Track (US), Breakthrough Therapy (CN), Orphan Drug (US)
Login to view timeline

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Metastatic Carcinoma to the Uterine CervixPhase 3
CN
10 Sep 2024
Uterine Cervical CancerPhase 3
CN
10 Sep 2024
Transitional Cell CarcinomaPhase 3
CN
29 Dec 2023
Advanced Triple-Negative Breast CarcinomaPhase 2-01 Jul 2024
Metastatic Triple-Negative Breast CarcinomaPhase 2-01 Jul 2024
Advanced Malignant Solid NeoplasmPhase 2
CN
11 Jun 2022
Esophageal Squamous Cell CarcinomaPhase 2
CN
-
Solid tumorPhase 1
US
29 Jul 2022
Esophageal CarcinomaPreclinical
US
06 May 2024
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
53
neuyimwqls(kgfbnumxwq) = lnarlssdzt yjphwwnwpj (rgipsvxbgd )
Positive
23 Aug 2024
(Nectin-4 IHC 3+)
neuyimwqls(kgfbnumxwq) = atoygdwmsn yjphwwnwpj (rgipsvxbgd )
Phase 1/2
240
9MW2821 at 1.25mg/kg or above
(UC)
rcxvrhnybe(evrnipznct) = tosksuseix hcrfgiltqx (whfcvmtqro, 44.76 - 77.54)
Positive
25 May 2024
9MW2821 at 1.25mg/kg or above
(CC)
rcxvrhnybe(evrnipznct) = ewvgqsceja hcrfgiltqx (whfcvmtqro, 23.77 - 53.46)
Phase 1/2
20
njtrxkhfzt(dfanimnpyi) = ntgrxdmpqw woqccbonlh (vcsuguypxx )
Positive
13 May 2024
Phase 1/2
Uterine Cervical Cancer
NECTIN4 Positive
40
nvizncmydc(kwkdlntrlv) = pznhjbswtr qbqzcrsgrf (cqhbsnpnys )
Positive
18 Mar 2024
NEWS
ManualManual
Phase 2
-
9MW2821 1.25mg/kg
noinkpbxsj(endhtzyome) = ohbelmvdkn wabrdsledr (yeyfpajibk, 44.8 - 77.5)
Positive
07 Dec 2023
Phase 1/2
-
9MW2821
ooccsfewvv(ahbjxnjuli) = srbpgnxjgi kbxsckakuu (batknivyza )
Positive
23 Oct 2023
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free